PMID: 9416779Jan 1, 1997Paper

A comparison of hepatic cytochrome P450 protein expression between infancy and postinfancy

Life Sciences
T TateishiS Kobayashi

Abstract

We immunochemically measured the contents of 9 different cytochrome P450 (CYP) isoenzymes expressed in the liver and compared them between two groups: one group of 6 infant and 4 perinatal patients and one group of 10 patients after infancy (over 1 year old). CYP protein expressed in human liver can be divided into three groups on the basis of expression pattern: (a) CYP2A6, 2C9, 2D6, 2E1, and 3A were present in all samples and no difference was observed between the two groups; (b) CYP1A2, 2B6, and 2C8 were expressed more after infancy than during infancy; and (c) CYP3A7, which has been considered a major CYP enzyme in fetal liver microsomes, was expressed in all infants as well as the four perinatal patients, whereas it was detected in only 2 patients after infancy. These results implied that CYP2A6, 2C9, 2D6, 2E1, and 3A are already expressed during perinatal and infant period, while CYP1A2, 2B6, and 2C8 are expressed highly in subjects over 1 year old, and CYP3A7 disappeared after infancy.

References

Sep 3, 1992·The New England Journal of Medicine·S J Fitzgibbons
Dec 5, 1991·European Journal of Biochemistry·J M TreluyerT Cresteil
Jun 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D RatanasavanhA Guillouzo
Jan 1, 1989·European Journal of Clinical Pharmacology·K PayneT Dawes
Jan 1, 1989·Annual Review of Pharmacology and Toxicology·F P Guengerich
Jan 1, 1989·Clinical Pharmacokinetics·P L Morselli
Sep 1, 1988·British Journal of Anaesthesia·H M MathewsJ W Dundee
Aug 15, 1985·Archives of Biochemistry and Biophysics·M KitadaY Kanakubo
Oct 1, 1980·Clinical Pharmacology and Therapeutics·J J Grygiel, D J Birkett
May 1, 1994·British Journal of Clinical Pharmacology·C CazeneuveG Olive
May 15, 1996·Archives of Biochemistry and Biophysics·Y LiT Kamataki

❮ Previous
Next ❯

Citations

Sep 21, 2001·Indian Journal of Pediatrics·M Yaster, D G Nichols
Oct 3, 2009·European Journal of Clinical Pharmacology·John T MondickJ Frank Hoke
Apr 23, 2003·Advanced Drug Delivery Reviews·Jane Alcorn, Patrick J McNamara
Feb 3, 2007·Nature Reviews. Drug Discovery·Amin Rostami-Hodjegan, Geoffrey T Tucker
Mar 10, 2012·Reproduction, Fertility, and Development·Manoja PretheebanDan Rurak
Jul 26, 2005·Pharmacogenetics and Genomics·Sarah C SimMagnus Ingelman-Sundberg
Aug 13, 2005·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Magnus Ingelman-Sundberg, Cristina Rodriguez-Antona
Oct 16, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yue Julia CuiCurtis D Klaassen
May 3, 2006·Biological & Pharmaceutical Bulletin·Masuhiro NishimuraAiko Yamauchi
Sep 12, 2002·Clinical Pharmacokinetics·Jane Alcorn, Patrick J McNamara
Jan 13, 2004·Clinical Pharmacokinetics·Jean-Xavier Mazoit, Bernard J Dalens
Jun 29, 2006·Clinical Pharmacokinetics·Andrea N EdgintonStefan Willmann
Aug 25, 2006·Clinical Pharmacokinetics·Trevor N JohnsonGeoffrey T Tucker
Feb 13, 2001·Biochemical and Biophysical Research Communications·G BertilssonP Blomquist
Mar 29, 2014·Clinical Pharmacokinetics·Farzaneh SalemAmin Rostami-Hodjegan
May 26, 2009·Biochemical Pharmacology·Edward L CroomErnest Hodgson
Nov 16, 2007·Pharmacology & Therapeutics·Magnus Ingelman-SundbergCristina Rodriguez-Antona
Aug 13, 2003·Journal of Clinical Pharmacy and Therapeutics·K TakahashiJ Azuma
May 17, 2008·Pediatric Transplantation·Guido FillerUwe Christians
Nov 13, 2007·British Journal of Clinical Pharmacology·Stefanie AlbersStephanie Läer
Dec 31, 2009·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Rebecca Brown DzubowStanley Barone
Nov 27, 2001·Biological Psychiatry·V HendrickA Fukuchi
Jul 11, 2008·Paediatric Anaesthesia·Amanda L PottsBrian J Anderson
Aug 28, 2009·Paediatric Anaesthesia·Amanda L PottsSanna Vilo
Aug 21, 2015·CNS Drugs·Vidya ChidambaranAjay D'Mello
Apr 20, 2012·Critical Reviews in Toxicology·Shakil Ahmed SaghirAlene Theresa McCoy
Aug 6, 2013·Toxicology in Vitro : an International Journal Published in Association with BIBRA·M J A JettenJ H M van Delft
Nov 6, 2013·Advanced Drug Delivery Reviews·Hannah K BatchelorSandra Klein
Jun 21, 2016·Toxicology Letters·Martin Krøyer RasmussenNiels Oksbjerg
Jun 28, 2013·Cell Transplantation·Laia TolosaM José Gómez-Lechón
Feb 13, 2018·Fundamental & Clinical Pharmacology·Virginia NeyroEvelyne Jacqz-Aigrain
Dec 2, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Silvia CarloniGiuseppe Buonocore
Jul 16, 2016·Journal of Clinical Pharmacology·Laura A WangUNKNOWN Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee
Aug 6, 2015·Transplantation·Felix KrenzienStefan G Tullius
May 29, 2004·Journal of Perinatology : Official Journal of the California Perinatal Association·Lisa R MoranRobert M Insoft
Feb 24, 2006·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Margaret A Adgent
Feb 26, 2019·British Journal of Clinical Pharmacology·Tamara van DongeJohn van den Anker
Mar 28, 2008·Therapeutic Drug Monitoring·Guido FillerUwe Christians
Mar 24, 2010·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·N Al Koudsi, R F Tyndale

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of Cardiology
M K WitteJ L Blumer
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Marc Le VeeOlivier Fardel
© 2021 Meta ULC. All rights reserved